Active16212266Private limited companyHarrogate

SANDOS PHARMA UK LTD

Significant control: Hadia Ibrahim Yousif Mohamed (75–100%)

From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms

Watch this company

Get an email when Companies House records a change for Sandos Pharma UK Ltd: status, filings, accounts, officers or owners. Free.

Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy

Coming soon · product and service lists

What does Sandos Pharma UK Ltd sell?

Registered activity: Manufacture of basic pharmaceutical products (SIC 21100). We’re building product and service lists for UK companies. Get this one when it’s ready.

One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy

Summary

Generated from filed data · no estimates

SANDOS PHARMA UK LTD is an active private limited company (company number 16212266) incorporated on 28 January 2025, registered in Harrogate. Its registered activity is manufacture of basic pharmaceutical products (SIC 21100). Latest dormant accounts cover the period ending 31 January 2026, showing net assets of £1 and cash of £1.

Peer position · net assets

By net assets it sits in the lower half of 85 comparable companies in Other (median £7,540, upper quartile £306k).

Ownership and control

1 active · 3 other

HI
Mrs Hadia Ibrahim Yousif Mohamed
Individual · since 29 June 2026
- owns 75–100% of shares
- owns 75–100% of shares
- owns 75–100% of shares
- holds 75–100% of voting rights
- holds 75–100% of voting rights
- holds 75–100% of voting rights
- can appoint or remove directors
- can appoint or remove directors
- can appoint or remove directors
75–100%
HN
Hikmat Noori Yousif Alankushee
Individual · since 28 January 2025 · ceased 22 June 2026
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
25–50%
AE
Ali Emad Oda Alfatlawi
Individual · since 28 January 2025 · ceased 22 June 2026
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
25–50%
AM
Mr Ashraf Mohammed Abdou Awad Ibrahim
Individual · since 22 June 2026 · ceased 29 June 2026
- owns 75–100% of shares
- owns 75–100% of shares
- owns 75–100% of shares
- holds 75–100% of voting rights
- holds 75–100% of voting rights
- holds 75–100% of voting rights
- can appoint or remove directors
- can appoint or remove directors
- can appoint or remove directors
75–100%

Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.

Key dates

Incorporated: 28 January 20251 yr ago
Next accounts due: 31 October 2027in 369 days
Confirmation statement due: 11 February 2027in 107 days

Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.

Activity

SIC 21100: Manufacture of basic pharmaceutical products
SIC 21200: Manufacture of pharmaceutical preparations
SIC 46460: Wholesale of pharmaceutical goods
SIC 46900: Non-specialised wholesale trade
Accounts type: Dormant
Size band: MicroCompanies Act thresholds

Financials

1 period on record · latest ending 31 January 2026

Net assets

£1

1 period on record

Cash at bank

£1

1 period on record

Turnover

Not reported

Employees

Not reported

Filed accounts by period, newest first
Period end	Net assets	Cash	Debtors	Creditors <1y	Turnover	Profit	Employees
31 January 2026	£1	£1	—	—	—	—	—

Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.

Filing and accounts signals

Facts from the register · no rating

Net assets above zeroNet assets £1 at 31 January 2026
Incorporated less than two years agoIncorporated 28 January 2025; no accounts due yet

Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.

Timeline

Newest first

31 Oct 2027Next accounts duein 369 days
11 Feb 2027Confirmation statement duein 107 days
31 Jan 2026Accounts period endNet assets £1 · dormant accounts
28 Jan 2025Incorporated

Similar companies in the UK

Same activity (manufacture of basic pharmaceutical products), closest in incorporation date

All companies incorporated on 28 January 2025 · in Jan 2025.

Reminders for SANDOS PHARMA UK LTD

Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.